EE05862B1 - Meditsiiniline plaaster - Google Patents

Meditsiiniline plaaster

Info

Publication number
EE05862B1
EE05862B1 EEP202200014A EEP202200014A EE05862B1 EE 05862 B1 EE05862 B1 EE 05862B1 EE P202200014 A EEP202200014 A EE P202200014A EE P202200014 A EEP202200014 A EE P202200014A EE 05862 B1 EE05862 B1 EE 05862B1
Authority
EE
Estonia
Prior art keywords
medical plaster
release
specifically
sodium salt
medical
Prior art date
Application number
EEP202200014A
Other languages
English (en)
Inventor
Carlo PIZZOCARO
Original Assignee
Fidia Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici S.P.A. filed Critical Fidia Farmaceutici S.P.A.
Publication of EE202200014A publication Critical patent/EE202200014A/et
Publication of EE05862B1 publication Critical patent/EE05862B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)

Abstract

Leiutis käsitleb meditsiinilist plaastrit, täpsemalt diklofenakki aeglaselt vabastavat meditsiinilist plaastrit, täpsemalt diklofenaki naatriumsoolal põhinevat meditsiinilist plaastrit, mille koostis võimaldab toimeainet vabastada pidevalt ja lokaalselt, terapeutiliselt aktiivses kontsentratsioonis 24 tunni jooksul, ning samuti polümeerset adhesiivmaatriksit (PSA) kasutamiseks diklofenaki naatriumsoolal põhinevas meditsiinilises plaastris.
EEP202200014A 2020-05-20 2021-05-18 Meditsiiniline plaaster EE05862B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102020000011686A IT202000011686A1 (it) 2020-05-20 2020-05-20 Cerotto medicato a lento rilascio

Publications (2)

Publication Number Publication Date
EE202200014A EE202200014A (et) 2022-12-15
EE05862B1 true EE05862B1 (et) 2024-01-15

Family

ID=71994907

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP202200014A EE05862B1 (et) 2020-05-20 2021-05-18 Meditsiiniline plaaster

Country Status (35)

Country Link
US (1) US20230190668A1 (et)
EP (1) EP4153151B1 (et)
KR (1) KR20230013033A (et)
CN (1) CN115666537A (et)
AR (1) AR122136A1 (et)
AT (1) AT525409A3 (et)
BE (1) BE1028251B1 (et)
CA (1) CA3178964A1 (et)
CH (1) CH718822B1 (et)
CZ (1) CZ2022461A3 (et)
DE (1) DE112021002871T5 (et)
DK (2) DK4153151T3 (et)
EE (1) EE05862B1 (et)
ES (2) ES2936185R1 (et)
FI (1) FI4153151T3 (et)
FR (1) FR3110397A1 (et)
GB (1) GB2610106B (et)
GR (1) GR1010304B (et)
HR (1) HRP20240192T1 (et)
HU (2) HUP2200459A2 (et)
IE (1) IE20210109A1 (et)
IT (1) IT202000011686A1 (et)
LT (1) LT4153151T (et)
LU (1) LU501245B1 (et)
MA (1) MA59594B1 (et)
MD (1) MD4153151T2 (et)
NL (1) NL2028233B1 (et)
PL (2) PL245596B1 (et)
PT (1) PT4153151T (et)
RO (1) RO137440A2 (et)
RS (1) RS65194B1 (et)
SI (1) SI4153151T1 (et)
SK (1) SK500562022A3 (et)
TR (1) TR2021008324A2 (et)
WO (1) WO2021234562A1 (et)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09208463A (ja) * 1996-02-07 1997-08-12 Tsumura & Co 経皮吸収性に優れた消炎鎮痛組成物
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
CN1215838C (zh) * 2003-06-25 2005-08-24 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
EP1877509B1 (en) 2005-03-17 2011-10-12 Pharmafilm S.R.L. An aqueous polymeric system for pressure sensitive adhesive matrix preparation
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
BR112013016998A2 (pt) 2010-12-29 2016-10-25 Pharmafilm S R L emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio
US20140100285A1 (en) * 2011-05-26 2014-04-10 Novartis Ag Compositions of percutaneous administration of physiologically active agents
PT2865378T (pt) * 2012-06-20 2018-01-15 Hisamitsu Pharmaceutical Co Adesivo para a pele
EP3206673B1 (en) 2014-10-17 2024-08-21 Fidia Farmaceutici S.p.A. Dermal therapeutic system with high adhesivity

Also Published As

Publication number Publication date
CH718822B1 (it) 2024-01-15
DE112021002871T5 (de) 2023-03-23
ES2936185A2 (es) 2023-03-14
CN115666537A (zh) 2023-01-31
GR20210100319A (el) 2021-12-09
RO137440A2 (ro) 2023-05-30
PL245596B1 (pl) 2024-09-02
CA3178964A1 (en) 2021-11-25
HRP20240192T1 (hr) 2024-05-10
GR1010304B (el) 2022-09-28
FR3110397A1 (fr) 2021-11-26
LU501245A1 (fr) 2022-02-15
GB2610106A (en) 2023-02-22
IT202000011686A1 (it) 2021-11-20
BE1028251A1 (fr) 2021-11-29
FI4153151T3 (fi) 2024-02-08
HUE066041T2 (hu) 2024-07-28
PL442805A1 (pl) 2023-07-03
PL4153151T3 (pl) 2024-04-22
AT525409A3 (de) 2023-04-15
NL2028233B1 (en) 2023-10-25
PT4153151T (pt) 2024-02-05
ES2972189T3 (es) 2024-06-11
NL2028233A (en) 2021-12-01
LT4153151T (lt) 2024-02-26
IE20210109A1 (en) 2022-08-17
GB2610106B (en) 2024-08-07
SK500562022A3 (sk) 2022-12-21
EP4153151A1 (en) 2023-03-29
EE202200014A (et) 2022-12-15
RS65194B1 (sr) 2024-03-29
MA59594B1 (fr) 2024-03-29
DK202201037A1 (en) 2022-11-21
KR20230013033A (ko) 2023-01-26
EP4153151B1 (en) 2023-11-22
TR2021008324A2 (tr) 2021-12-21
WO2021234562A1 (en) 2021-11-25
SI4153151T1 (sl) 2024-03-29
MD4153151T2 (ro) 2024-04-30
US20230190668A1 (en) 2023-06-22
ES2936185R1 (es) 2023-10-11
BE1028251B1 (fr) 2022-04-05
LU501245B1 (fr) 2022-05-17
DK4153151T3 (da) 2024-02-05
HUP2200459A2 (hu) 2023-03-28
GB202217015D0 (en) 2022-12-28
AT525409A2 (de) 2023-03-15
AR122136A1 (es) 2022-08-17
CZ2022461A3 (cs) 2022-12-14

Similar Documents

Publication Publication Date Title
MX2007004862A (es) Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias.
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
NZ610701A (en) Once daily formulation of lacosamide
MX2007004861A (es) Derivados de sulfonamida novedosos como moduladores de receptor glucocorticoide para el tratamiento de enfermedades inflamatorias.
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
MX2009009623A (es) Inidol y bencimidazol amidas como inhibidores de la dehidrogenasa hidroxi-esteroide.
JP6142379B2 (ja) 含水貼付剤
DE602006004451D1 (de) Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen
MX360289B (es) Composiciones de tapentadol.
NZ594618A (en) Transdermal pharmaceutical preparations
EA201500553A1 (ru) Многодневный пластырь для чрескожного введения ротиготина
US8852628B1 (en) Transdermal drug delivery system for diclofenac
ATE476972T1 (de) Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris
AR044200A1 (es) Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo
PE20040416A1 (es) Formulacion de alta dosis de ibandronato
AR038618A1 (es) Forma poliformica cristalina de clorhidratos de irinotecan
WO2008151040A3 (en) Analgesic coated medical product
EE202200014A (et) Meditsiiniline plaaster
UY31058A1 (es) Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
RU2013157834A (ru) Композиции для подкожного введения физиологически активных средств
TW200500093A (en) A platform for transdermal formulations (PTF)
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
NZ703464A (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
JP5948322B2 (ja) ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法